Carlotta Antoniotti

7.8k citations
109 papers · 2.6k indexed · 2 hit papers · h-index 19
Topics
Colorectal Cancer Treatments and Studies (96 papers)Cancer Treatment and Pharmacology (30 papers)Hepatocellular Carcinoma Treatment and Prognosis (27 papers)

In The Last Decade

Carlotta Antoniotti

103 papers receiving 2.6k citations

Hit Papers

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizuma...201520262018202220152015200400600

Peers

Carlotta Antoniotti
Comparison fields: 5 of 86
  • Oncology 2.3k
  • Pathology and Forensic Medicine 932
  • Pulmonary and Respiratory Medicine 819
  • Hepatology 597
  • Cancer Research 483
Replace Robert Lim with:
Robert Lim United States
Wendy De Roock Belgium
Linda Mol Netherlands
Bart Biesmans Belgium
Ralph Wong Canada
J-Y Douillard France
Sara De Dosso Switzerland
Silvana Chiara Italy
Martin Šmakal United States
Pilar García‐Alfonso Spain
Carlotta Antoniotti relative to Robert Lim United States Robert Lim's profile →
Citations per field
00.5×3.4×
Robert Lim · 1×
Citations per year

Countries citing papers authored by Carlotta Antoniotti

Since Specialization
Citations

This map shows the geographic impact of Carlotta Antoniotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlotta Antoniotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlotta Antoniotti more than expected).

Fields of papers citing papers by Carlotta Antoniotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlotta Antoniotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlotta Antoniotti. The network helps show where Carlotta Antoniotti may publish in the future.

Co-authorship network of co-authors of Carlotta Antoniotti

This figure shows the co-authorship network connecting the top 25 collaborators of Carlotta Antoniotti. A scholar is included among the top collaborators of Carlotta Antoniotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlotta Antoniotti. Carlotta Antoniotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 1
5 1
6 6
7 18
8 1
9 2
10 7
11 2
12 12
13 35
14 4
15 5
16 8
17 3
18 2
19 5
20
Folfoxiri plus Bevacizumab as first-line treatment of BRAF mutant metastatic colorectal cancer patients.
4

About Carlotta Antoniotti

Carlotta Antoniotti is a scholar working on Oncology, Hepatology and Cancer Research, having authored 109 papers that have together received 2.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (96 papers), Cancer Treatment and Pharmacology (30 papers) and Hepatocellular Carcinoma Treatment and Prognosis (27 papers). The work is most often cited by research in Oncology (2.3k citations), Hepatology (597 citations) and Pathology and Forensic Medicine (932 citations). Carlotta Antoniotti has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Chiara Cremolini, Alfredo Falcone, Fotios Loupakis, Gianluca Masi, Gabriella Fontanini, Sara Lonardi, Elisa Sensi, Cristiana Lupi, Lisa Salvatore and Marta Schirripa. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026